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Abstract: Hepatitis delta virus (HDV) is a distant relative of plant viroids in the animal 
world. Similar to plant viroids, HDV replicates its circular RNA genome using a double 
rolling-circle mechanism. Nevertheless, the production of hepatitis delta antigen (HDAg), 
which is indispensible for HDV replication, is a unique feature distinct from plant viroids, 
which do not encode any protein. Here the HDV RNA replication cycle is reviewed, with 
emphasis on the function of HDAg in modulating RNA replication and the nature of the 
enzyme involved. 
Keywords: hepatitis delta virus; hepatitis delta antigen; RNA-dependent RNA synthesis; 
RNA polymerases; RNA replication 
 
1.  Introduction 
Hepatitis delta virus (HDV) was first discovered in 1977 among a group of patients infected with 
hepatitis B virus (HBV) [1]. Subsequent studies revealed that HDV is a defective virus, which requires 
a helper virus, HBV, to supply the hepatitis B surface antigen (HBsAg) for virion assembly and 
infectivity [2–4]. Being a human pathogen, HDV may lead to progressive chronic liver disease and 
occasional fulminant hepatitis in patients coinfected or superinfected with HBV [5,6]. In recent years, 
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the incidence of new HDV infection has significantly declined in some parts of the world due to HBV 
vaccination. However, investigation of the HDV life cycle has raised many issues which molecular 
biologists are interested in.  
Unlike other RNA satellite viruses which rely on the RNA-dependent RNA polymerase (RdRp) 
provided by the coexisting helper virus for genome replication, the dependence of HDV on HBV is 
limited to the supply of HBsAg for the production of HDV viral particle. Similar to plant viroids which 
do not encode RdRp, HDV undergoes robust RNA replication autonomously once inside the cells. 
Thus, it is certain that HDV and plant viroids have to replicate their RNA genome using a cellular 
enzyme(s). Unlike plant viroids which do not encode any protein, HDV encodes a protein, hepatitis 
delta antigen (HDAg), which is intimately involved in its RNA replication. In addition, HDV RNA not 
only has to replicate itself but also needs to transcribe a subgenomic mRNA species coding for HDAg. 
The transcription of the HDAg-encoding mRNA has all of the hallmarks of the cellular mRNA 
transcription except for the nature of the template (DNA versus RNA). Therefore, distinct from plant 
viroids, HDV represents a hybrid of the conventional DNA-dependent transcription and the unique 
RNA-dependent RNA synthesis in the absence of an RdRP. To coordinate with this sophisticated and 
unique RNA amplification process in mammalian cells, HDAg plays important regulatory roles which 
will be reviewed herein. Additionally, the nature of the enzyme involved in HDV RNA replication will 
also be addressed. 
2.  Structure of HDV and HDV RNA 
The HDV virion is a spherical particle of about 36-nm in diameter, which contains an envelope with 
HBsAg and a nucleocapsid containing an RNA genome in complex with HDAg [7,8]. Genomic HDV 
RNA is approximately 1.7 kb in length and consists of a single-stranded, circular RNA of negative 
polarity, with a high degree of intra-molecular base paring that allows it to fold into an unbranched 
rod-like structure under the native condition [9,10] (Figure 1). Albeit the fact that HDV RNA is three 
to four times longer than plant viroids, the semi-double-strand structure of HDV RNA is very similar 
to that adopted by viroid RNAs. The extra sequence of HDV RNA contains an open reading frame 
(ORF) which is responsible for the coding of HDAg on the complementary strand (antigenomic RNA). 
HDV also contains ribozyme domains on both the genomic and antigenomic strands, which are 
required for the cleavage of the respective RNA strands in cis during RNA replication [11,12]   
(Figure 1). This is another feature shared between HDV RNA and some plant viroids.  
3.  HDAg 
The production of HDAg, which is intimately involved in HDV RNA replication, is a unique 
feature distinguishing HDV from plant viroids, the latter of which do not encode any protein. HDAg 
exists as two distinct protein species, the small isoform of 195 amino acid residues in length (S-HDAg; 
24 kDa) and the large isoform of 214 amino acid residues in length (L-HDAg; 27 kDa). The amino 
acid sequences of these two isoforms are identical except that L-HDAg contains an additional 19 
amino acids at the very end of its C-terminus, which results from a specific RNA editing event at the 
termination codon during the late stage of viral replication [13–15]. With the exception of C-terminal 
extension in the L-HDAg, these two HDAg isoforms share several functional domains, including Viruses 2009, 1                  
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RNA-binding motifs, a nuclear localization signal (NLS), a coiled-coil domain, a helix-loop-helix 
motif, and a C-terminal stretch of proline- and glycine-rich sequence (Figure 2). However, these two 
HDAg isoforms exhibit different functions in the HDV life cycle. S-HDAg is required for HDV RNA 
replication [16], whereas L-HDAg is required for virus assembly [17,18]. Correspondingly, the virus 
assembly signal is situated in the C-terminal 19 amino acids of L-HDAg. In addition, HDAg can be 
posttranslationally modified by methylation, acetylation, and phosphorylation and, in the case of   
L-HDAg, prenylation. Arg-13 Methylation, Lys-72 acetylation, and Ser-177 phosphorylation are three 
major modifications of S-HDAg and are important for the functions of S-HDAg in HDV RNA 
replication [19–22], namely, the unmodified and modified forms of HDAg are involved in different 
steps of HDV RNA replication (see below). Cys-211 prenylation of L-HDAg is required for virus 
packaging  [23] (Figure 2). More recently, we found that HDAg can also be modified by sumoylation 
(unpublished observation).  
Figure 1. Schematic diagrams of the structure of HDV RNAs. The antigenomic RNA and 
HDAg-encoding mRNA are detected only in the cells. The nucleotide numbers are 
according to Makino et al.  [24] and represented in genomic orientation on both the 
genomic and antigenomic strands. The genomic RNA is represented in clockwise 
orientation, while the antigenomic RNA and HDAg-encoding mRNA are 
counterclockwise. Nucleotides 688/689 and 903/904 are ribozyme cleavage sites for 
genomic and antigenomic RNAs, respectively. The hatched boxes represent the ribozyme 
domains. Nucleotides 1015 (Ed) denotes RNA editing site. (A)n represents polyadenylation 
signal. 
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Figure 2. The functional domains and sites of posttranslational modifications of HDAg. 
RBD, RNA-binding domain; CCD, coiled-coil domain; NLS, nuclear localization signal; 
HLH, helix-loop-helix motif; PGRS proline/glysine-rich sequence; VAS, virus assembly 
signal; M, methylation; A, acetylation; P, phosphorylation; Pr, prenylation. 
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4.  An Overview of the HDV Replication Cycle  
Because of the lack of a convenient cell culture model system for HDV infection, many of the 
details of the HDV life cycle are still unclear. In natural infection, HDV presumably enters its host 
cells through a cellular receptor shared with HBV inasmuch as the initiation of infection of both these 
viruses depends on the large form of HBsAg in the viral envelope [4]. The subsequent steps, from 
virus absorption, penetration, and delivery of the viral genome to its nuclear replication site, are still 
unclear although the nuclear transportation step is most likely mediated by the HDAg present in the 
infecting RNP complex  [25–27]. As for the HDV RNA genome replication, available evidence 
supports the hypothesis that HDV replicates its RNA genome by a double rolling-circle 
mode  [16,28,29] similar to that proposed for plant viroids  [30]. In this model, the input circular 
genomic RNA serves as a template for the initial round of RNA replication to generate a multimeric 
antigenomic RNA intermediate. As RNA synthesis continues, unit-length monomer of antigenomic 
RNA intermediate is self-cleaved from the growing transcript by the intrinsic ribozyme activity [11,12] 
and ligated into a circular form by a cellular RNA ligase  [31]. Subsequently, this circularized 
antigenomic RNA monomer serves as template for the second round of rolling-circle replication to 
generate a circular genomic RNA.  
The above replication model can only account for the synthesis of full-length genomic and 
antigenomic RNA. However, in addition to the monomeric and multimeric HDV RNAs of genomic 
and antigenomic sense, HDV has to produce a 0.8-kb subgenomic mRNA species for the coding of 
HDAg (HDAg-encoding mRNA), which is absolutely required for HDV replication (Figure 1). This 
subgenomic mRNA is of antigenomic sense and has all the hallmarks of cellular mRNA (e.g., it is 
capped and polyadenylated). Therefore, distinct from plant viroids, HDV has to carry out mRNA 
transcription in concert with the replication of the genomic and antigenomic RNA. It is still 
controversial how the subgenomic mRNA transcription fits into the rolling-circle scheme of HDV 
RNA replication. Previously it was proposed that the subgenomic mRNA transcription occurs only at 
the beginning of HDV RNA genome replication and is an adjunct of rolling-circular replication [32]. 
However, new findings support an alternative hypothesis that the synthesis of subgenomic mRNA and 
replication of the HDV genome are independent processes and take place in parallel, probably in 
different replication and transcription complexes [33]. Viruses 2009, 1                  
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During HDV RNA replication, an RNA editing event occurs on the antigenomic strand [34,35] by a 
cellular double-stranded RNA-adenosine deaminase [15]. This event converts the amber termination 
codon of the S-HDAg reading frame to a trp-coding sequence, thus extending the reading frame for an 
additional 19 amino acids to encode L-HDAg. At the late stage of HDV replication, interaction of  
L-HDAg with HBsAg, which is provided by its helper virus HBV, leads to the production of virus 
particles [2,4]. 
5.  The Role of HDAg in HDV RNA Replication 
Unlike plant viroids which do not have coding capacity, approximately 3/4 of the length of the 
HDV RNA rod-like structure encompasses the HDAg-coding region (Figure 1). Due to the fact that the 
HDV genome can replicate independently of HBV, the study of HDV RNA replication has been 
carried out extensively by transfecting cultured cells with HDV cDNA or RNA. It is worthy to note 
that in such experiments, a functional S-HDAg, which is either generated endogenously from the 
transfected HDV cDNA or provided exogenously (either from a cotransfected S-HDAg expression 
plasmid or a cotransfected S-HDAg-encoding mRNA, or, alternatively, cotransfected with 
recombinant S-HDAg protein), is required for establishing HDV RNA replication in the cells. 
Additionally, site-directed mutageneses on most sites in the HDAg-coding sequences resulted in the 
inhibition of HDV RNA replication; the replication defects could be rescued by a wild-type S-HDAg 
supplemented in trans [36–38]. Thus, it is concluded that S-HDAg is absolutely required for HDV 
RNA replication. However, several studies on in vitro transcription of partial HDV RNA sequences 
have been achieved in the absence of S-HDAg. Nevertheless, the length of the transcripts obtained in 
such in vitro reactions was usually very short [39–41] and the addition of S-HDAg was shown to be 
able to stimulate the transcription reaction [42]. Thus, S-HDAg is likely a positive factor for HDV 
RNA replication. 
6.  The Functions of HDAg 
(i) HDAg as a carrier for nuclear import of HDV RNA 
S-HDAg has been known to transport HDV RNA to its site of replication. A nuclear import assay 
demonstrated that HDAg mediates nuclear import of HDV RNA, and that both the NLS and   
RNA-binding motif of S-HDAg are required for the RNA-transporting activity [27]. Additionally, a 
heterokaryon assay also showed that the HDV ribonucleoprotein shuttles continuously between the 
nucleus and the cytoplasm  [26]. In that study, in the absence of S-HDAg, HDV RNA was 
predominantly detected in the cytoplasm; however, coexpression of HDV RNA and S-HDAg resulted 
in nuclear accumulation of viral RNA. Accordingly, the first biological function of S-HDAg involved 
in HDV RNA replication is likely to deliver the viral genome to its nuclear replication site.  
(ii) HDAg as a transcription regulator for Pol II  
Given that S-HDAg possesses no RdRp activity and that HDV undergoes robust RNA replication 
autonomously once inside the cells, it is certain that the replication of HDV RNA, similar to that of 
plant viroids, is mediated by a cellular polymerase(s). Several lines of evidence suggest that cellular Viruses 2009, 1                  
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DNA-dependent RNA polymerase II (Pol II) is involved in HDV RNA replication (see below). Other 
than serving as a transporter of HDV RNA, S-HDAg is also likely a component of the RNA synthetic 
machinery. S-HDAg has many features reminiscent of transcription regulators. It is a nuclear protein 
which contains coiled-coil and helix-loop-helix domains. Similar to many DNA-dependent 
transcription factors and core histones, which are subject to posttranslational protein modifications, S-
HDAg can also be phosphorylated, acetylated and methylated, and these modifications play regulatory 
roles in HDV RNA replication [19–22]. Besides, like many cellular and viral nuclear proteins which 
function in transcriptional regulation, S-HDAg is also sumoylated (unpublished observation). S-HDAg 
also shares some sequence similarity with the transcription elongation factor NELF-A (the subunit A 
of negative elongation factor) [42]. In a Pol II-mediated in vitro transcription system, S-HDAg was 
shown to be able to promote RNA elongation by displacing NELF-A [42]. Furthermore, HDAg has 
also been shown to interact with cellular transcription factor YY1 and its associated acetyltransferases 
CBP and p300 in a large nuclear complex, which, in turn, modulates HDV RNA replication [43]. 
Although the role of S-HDAg in the initiation of HDV RNA replication has not been directly 
demonstrated, a few reports demonstrated that S-HDAg can directly bind to Pol II and stimulate Pol II 
elongation to some degree on both DNA-templated and HDV RNA-templated transcription in 
vitro [42,44,45]. A more recent report further showed that binding of S-HDAg to the clamp of Pol II 
not only increases the rate of Pol II-mediated transcriptional elongation but also affects transcriptional 
fidelity [46]. Collectively, these lines of evidence suggest that S-HDAg is a component of the RNA 
synthetic machinery and involved in both the initiation and the elongation (maintenance) of HDV 
RNA replication.  
(iii) HDAg as an RNA chaperone 
HDAg may also play a role in posttranscriptional RNA processing. As mentioned above, HDV 
RNA replication is thought to be carried out through a double-rolling-circle mechanism, in which the 
autocatalytic self-cleavage and the subsequent ligation process are involved. In an in vivo study, 
HDAg was shown to be able to enhance the self-cleavage activity of HDV RNA and the subsequent 
circularization of HDV RNA [47]. Moreover, a series of in vitro studies showed that the N-terminal 
domain of HDAg can modulate the self-cleavage activities of HDV RNA fragments and facilitate a 
trans-acting hammerhead ribozyme to find its target in RNAs of various sequences and lengths 
 [48–50]. Based on the results from these studies, it is suggested that HDAg has a biological role as an 
RNA chaperone to modulate the cleavage and ligation of HDV RNA during the HDV life cycle.  
(iv) L-HDAg and RNA replication 
During HDV replication, the amount of L-HDAg is accumulated through time. L-HDAg contains all 
the functional domains of S-HDAg, with additional 19 amino acids at the C-terminus. However, the 
biological effects of these two isoforms are much different. In addition to playing a prerequisite role in 
virion packaging [17,18], L-HDAg has been shown to potentially inhibit HDV RNA replication, thus 
playing a modulating role in viral RNA replication  [51,52]. However, the ability of L-HDAg to 
regulate HDV RNA synthesis in the natural HDV life cycle is still in debate. Although the excessive 
RNA editing was shown to result in the inhibition of RNA replication of some HDV Viruses 2009, 1                  
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genotypes [14,53], it is still not clear whether this inhibition was caused by L-HDAg per se or the 
editing-induced hypermutations of the HDV genome [54]. Furthermore, it has also been shown that the 
presence or absence of L-HDAg did not affect the steady-state level of HDV RNA late in the viral 
replication cycle [55]. Regardless of whether L-HDAg does or does not inhibit HDV RNA replication, 
its role in HDV RNA replication is of considerable interest, as L-HDAg is usually co-localized with  
S-HDAg [56] and has been found to be in the promyelocytic leukemia (PML) body of the nucleus 
[57], which is near the site of HDV RNA replication [58].  
7.  Enzymology of HDV RNA Replication 
Cellular Pol II is responsible for DNA-dependent RNA synthesis during gene transcription. 
Nevertheless, there is evidence that Pol II also possesses RdRP activity [59,60]. Pol II has long been 
implicated in the replication of RNA genome of plant viroids and HDV. The first evidence suggesting 
that Pol II is involved in HDV replication came from a nuclear run-on experiment [61]. In that study, it 
was shown that HDV RNA synthesis could be inhibited by a low concentration of α-amanitin. In 
support of this observation, relevant studies, based on in vivo or in vitro approaches, provided further 
evidence on the involvement of this polymerase in HDV RNA replication [40,62–64]. Recent HDV 
RNA immunoprecipitation studies also confirmed the interaction between Pol II and HDV RNA 
[65,66]. Furthermore, in a recent significant report, the RdRP activity of Pol II was biochemically and 
structurally characterized [67]. In that study, while it is less processive than regular DNA-dependent 
RNA synthesis, the RdRP activity can be obtained using part of the HDV antigenome as template. 
Combined with the fact that HDAg-encoding mRNA has all of the hallmarks of the conventional Pol 
II-mediated mRNA transcripts in the cells (e.g., 5’ capped and 3’ polyadenylated) [32,41], it is 
generally accepted that Pol II is involved in HDV RNA synthesis. 
HDV RNA replication includes the transcription of HDAg-encoding mRNA (from the genomic 
template), the synthesis of antigenomic RNA (also from the genomic template), and the synthesis of 
genomic RNA (from the antigenomic template). Indeed, it has been demonstrated that HDV mRNA 
transcription and genomic RNA synthesis are both inhibited by α-amanitin at 1 to 5 μg/mL, consistent 
with  α-amanitin sensitivity of Pol II [29,63,68]. Similar to cellular mRNA transcripts, the HDV 
genomic RNA are synthesized in the nucleoplasm [58] and exported to the cytoplasm immediately 
after synthesis [68]. Besides, the HDAg-encoding mRNA has all of the hallmarks of the conventional 
Pol II-mediated mRNA transcripts. Hence, it is very likely that both the HDV mRNA transcription and 
genomic RNA synthesis are carried out by the Pol II machinery. In contrast, relevant studies have 
found that the metabolic requirements for the synthesis of antigenomic RNA are significantly different 
from that for the synthesis of genomic RNA or the transcription of mRNA (Table 1). In contrast to the 
synthesis of genomic RNA and the transcription of mRNA which could be inhibited by a low 
concentration of α-amanitin, the antigenomic RNA synthesis is resistant to high concentration   
(10–100 μg/mL) of the drug [29,63,68]. As mentioned above, S-HDAg is indispensible for HDV RNA 
replication. Significantly, the synthesis of antigenomic RNA and the synthesis of the other two RNA 
species require different posttranslational modifications of S-HDAg  [19–22,25]. Specifically, the 
genomic RNA synthesis and the transcription of mRNA require an S-HDAg that is acetylated, 
methylated and phosphorylated; in contrast, the antigenomic RNA synthesis can be mediated by an Viruses 2009, 1                  
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unmodified S-HDAg. In addition, the genomic RNA synthesis is inhibited by L-HDAg when the latter 
is expressed at the beginning of the replication cycle, whereas the antigenomic RNA synthesis is not 
inhibited  [55]. Furthermore, the RNA-exporting capacity is also different. As a protein-encoding 
mRNA, it is conceivable that HDV mRNA has to be transported to the cytoplasm after being 
transcribed. Similarly, the genomic RNA is also exported to the cytoplasm immediately after its 
synthesis; in contrast, the antigenomic RNA is retained in the nucleus after being synthesized [68]. 
Taken together, these prominent differences suggest that the cellular transcription machinery involved 
in the synthesis of antigenomic RNA is different from that of genomic RNA and HDAg-encoding 
mRNA.  
Table 1. Comparison of metabolic requirements for the synthesis of the various HDV RNA 
species 
a. 
Characteristic 
mRNA 
transcription 
(G to m) 
Genomic RNA 
synthesis 
(AG to G) 
Antigenomic RNA          
      synthesis                     References   
(G to AG) 
S-HDAg requirement      
R-13 methylation  Yes  Yes  No                                19,22 
K-72 acetylation  Yes  Yes  No                                21,22 
S-177 phosphorylation  Yes  Yes  No                                20,22 
Assisted by recombinant 
S-HDAg from E. coli 
?  No  Yes                                 25 
Cytoplasmic transport  
after synthesis 
Yes  Yes  No                                  68 
Inhibition by L-HDAg ?  Yes  No                                  55 
Sensitive to low 
concentration of α-
aminitin (1–5 μg/mL) 
Yes  Yes  No                           29,58,63,68 
Site of synthesis  nucleoplasm  nucleoplasm  Nucleolus                        58,71 
Polymerases  Pol II  Pol  II  Pol I  (?)           32,40,41,58,61-64,67,72 
a G, genomic RNA; AG, antigenomic RNA; m, HDAg-encoding mRNA.
 
 
The finding that the synthesis of the antigenomic RNA is insensitive to high concentration of   
α-amanitin [29,63,68] suggests the involvement of other polymerases, such as Pol I. Previously, it has 
been demonstrated that nucleolar proteins, B23 and nucleolin, interact with HDAg and are involved in 
the modulation of HDV RNA replication  [69,70]. A recent study using metabolic labeling and 
immunofluorescence staining confirmed that HDV RNA synthesis had both α-amanitin-sensitive and  
-resistant components. The antigenomic RNA labeling was α-amanitin-resistant and localized to the 
nucleolus [58]. Besides, results in that study also showed that the Pol I-associated transcription factor 
SL1 could be precipitated together with HDAg and the depletion of SL1 down-regulated HDV RNA 
synthesis. A more recent study has also shown that an S-HDAg chimeric mutant which is confined to 
the nucleoli can support the synthesis of antigenomic RNA but not genomic RNA [71]. Furthermore, 
the direct interaction of HDV RNA with Pol I has been demonstrated in a recent report  [72]. 
Collectively, distinct from the proposition that HDV mRNA transcription and genomic RNA synthesis Viruses 2009, 1                  
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are carried out by the Pol II transcription machinery in the nucleoplasm, accumulating evidence 
suggests that the antigenomic RNA synthesis occurs in the nucleolus and carried out by the Pol I 
transcription machinery. However, the direct evidence that Pol I can carry out RNA-dependent RNA 
synthesis is still lacking. 
8.  Perspectives 
In recent years, the prevalence of HDV infection is decreasing partly ascribed to HBV vaccination. 
Nevertheless, HDV remains an important model system for the understanding of RNA biology. HDV 
RNA genome replication involves its only protein HDAg and several steps of RNA amplification and 
processing. There are still many unanswered questions concerning these events; chief among them is 
the nature of the RNA replication enzymes involved in HDV life cycle. Pol II has long been suspected, 
but Pol I has now been implicated in the antigenomic RNA synthesis. Furthermore, it has been recently 
shown that not only Pol II and Pol I but also Pol III directly bind to HDV RNA genome [66,72], 
suggesting a higher level of complexity in HDV RNA replication. Although accumulating evidence 
suggests that HDV relies on cellular DNA-dependent RNA polymerases to carry out RNA-dependent 
RNA replication, there is still a remote possibility that a previously unrecognized RNA-dependent 
RNA polymerase (RdRP) is involved in these processes. Recently, the identification of a mammalian 
RdRP [73] behooves this possibility to be taken seriously into consideration. A fundamental issue is 
how HDV genomic RNA is used simultaneously for antigenomic RNA synthesis and mRNA 
transcription. The separation of these two functions into different transcription machineries, Pol I vs. 
Pol II, using different modified forms of HDAg as transcription factors, and taking place in different 
subcellular compartments can solve this dilemma.  
A unique feature of HDV RNA replication is its strict requirement for HDAg. There are a number of 
important issues in this regard requiring further investigation: 
1. What is the detailed mechanism of individual posttranslational modification of S-HDAg 
involved in modulating Pol II-mediated HDV antigenomic RNA synthesis and HDAg-encoding 
mRNA transcription? For this aspect, antibodies to posttranslationally modified S-HDAg may be 
powerful tools to dissect roles of the modified S-HDAg.  
2. What is the crosstalk between different posttranslationally modified S-HDAg? Whether S-HDAg 
can be posttranslationally modified (by methylation, acetylation, phosphorylation and 
sumoylation) sequentially and/or synergistically for its function in redirecting the Pol-II 
transcription complex is worthy of further exploration.  
3. The fact that unmodified S-HDAg can support HDV antigenomic RNA synthesis implies that the 
crosstalk between S-HDAg and Pol I transcription complex (or other novel polymerases) is 
simpler as compared to the crosstalk between modified-S-HDAg and Pol II transcription 
complex. Hence, an in-vitro reconstitution assay of Pol I-mediated HDV antigenomic RNA 
synthesis might be feasible.  
HDV RNA replication represents a new facet of cellular transcription machinery. The answers to 
how the cellular enzymes are redirected and regulated for HDV RNA synthesis will reveal new 
insights into the molecular biology of cells and viruses.  Viruses 2009, 1                  
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